Kodiak Sciences Inc (KOD)

Apr 18, 2025

April 2025's Promising Penny Stocks - Yahoo Finance

Apr 18, 2025

Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights - openPR.com

Apr 17, 2025

Apr 17, 2025

Age Related Vision Dysfunction Market to Reach New Heights in Growth by 2034, DelveInsight Predicts | Kodiak Sciences Inc., Outlook Therapeutics, Eye point Pharmaceuticals - The Globe and Mail

Apr 17, 2025

Apr 11, 2025

Wet Age-Related Macular Degeneration Therapeutics Market Size - openPR.com

Apr 11, 2025

Apr 09, 2025

Sei Investments Co. Sells 69,599 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Apr 09, 2025

Apr 04, 2025

Kodiak Sciences stock hits 52-week low at $2.15 - Investing.com India

Apr 04, 2025

Apr 04, 2025

HC Wainwright Comments on Kodiak Sciences Q2 Earnings - Defense World

Apr 04, 2025

Apr 03, 2025

HC Wainwright Forecasts Kodiak Sciences Q1 Earnings - Defense World

Apr 03, 2025

Apr 01, 2025

Down -28.08% in 4 Weeks, Here's Why You Should You Buy the Dip in Kodiak Sciences (KOD) - Yahoo Finance

Apr 01, 2025

Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target By Investing.com - Investing.com South Africa

Mar 31, 2025

Mar 31, 2025

H.C. Wainwright holds Kodiak Sciences stock at Neutral, $3 target - Investing.com

Mar 31, 2025

Mar 28, 2025

Kodiak Q4 Loss Narrower Than Expected, Pipeline Development in Focus - MSN

Mar 28, 2025

Mar 28, 2025

Charles Schwab Investment Management Inc. Sells 6,758 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 28, 2025

Mar 28, 2025

Kodiak Sciences Advances Retinal Therapies with Promising Pipeline - TipRanks

Mar 28, 2025

Mar 27, 2025

Kodiak Sciences Inc reports results for the quarter ended December 31Earnings Summary - TradingView

Mar 27, 2025

Mar 27, 2025

KODIAK SCIENCES Earnings Results: $KOD Reports Quarterly Earnings - Nasdaq

Mar 27, 2025

Mar 27, 2025

Kodiak Sciences Cuts Losses by 26%, Advances Two Phase 3 Trials with $168M War Chest - Stock Titan

Mar 27, 2025

Mar 26, 2025

Is Kodiak Sciences Inc. (KOD) The Hot Biotech Stock Under $5? - Insider Monkey

Mar 26, 2025

Mar 26, 2025

Bank of New York Mellon Corp Purchases 4,927 Shares of Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Mar 26, 2025

Mar 24, 2025

Diabetic Macular Edema Pipeline 2025: Therapies Under - openPR

Mar 24, 2025

Mar 24, 2025

Kodiak Sciences Inc expected to post a loss of 88 cents a shareEarnings Preview - TradingView

Mar 24, 2025

Mar 24, 2025

Critical Contrast: Metagenomi (NASDAQ:MGX) & Kodiak Sciences (NASDAQ:KOD) - Defense World

Mar 24, 2025

Mar 21, 2025

10 Hot Biotech Stocks Under $5 - Insider Monkey

Mar 21, 2025

Mar 19, 2025

Retinal Vein Occlusion Clinical and Non-Clinical Studies, Key - openPR

Mar 19, 2025

Mar 18, 2025

KOD Completes Enrollment in Phase III Study for Eye Disease Candidate - MSN

Mar 18, 2025

Mar 12, 2025

Diabetic Retinopathy Clinical Trials and Studies: EMA, PDMA, FDA Approvals, Mechanism of Action, ROA, NDA, IND, and Companies - The Globe and Mail

Mar 12, 2025

Mar 12, 2025

Why Palantir (PLTR) Stock Is Up Today - The Globe and Mail

Mar 12, 2025

Mar 10, 2025

Kodiak Sciences Completes Enrollment in Second Registrational Trial of Tarcocimab in Patients with Diabetic Retinopathy - Marketscreener.com

Mar 10, 2025

Mar 10, 2025

Kodiak Sciences completes enrollment in GLOW2 Phase 3 trial - TipRanks

Mar 10, 2025

Mar 10, 2025

KODKodiak Sciences Inc. Latest Stock News & Market Updates - StockTitan

Mar 10, 2025

Mar 10, 2025

CDC To Study Vaccines and Autism, Despite Much Research Showing No Link - 69News WFMZ-TV

Mar 10, 2025

Mar 10, 2025

Clinical Trial Success: Kodiak Enrolls 250+ Patients for Novel Diabetic Eye Drug - Stock Titan

Mar 10, 2025

Mar 04, 2025

Diabetic Retinopathy Pipeline 2025: Mechanism of Action, Route - openPR

Mar 04, 2025

Feb 25, 2025

We're Keeping An Eye On Kodiak Sciences' (NASDAQ:KOD) Cash Burn Rate - Yahoo Finance

Feb 25, 2025

Feb 23, 2025

Kodiak Sciences’ Anti-VEGF Could Win Nicely On Retinal Disorders (NASDAQ:KOD) - Seeking Alpha

Feb 23, 2025

Feb 20, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Sees Large Increase in Short Interest - MarketBeat

Feb 20, 2025

Feb 17, 2025

Elisa Oyj (OTCMKTS:ELMUF) Short Interest Update - Defense World

Feb 17, 2025

Feb 17, 2025

Kodiak Sciences Inc. (NASDAQ:KOD) Sees Significant Growth in Short Interest - Defense World

Feb 17, 2025

Feb 15, 2025

166,843 Shares in Kodiak Sciences Inc. (NASDAQ:KOD) Bought by Peapod Lane Capital LLC - MarketBeat

Feb 15, 2025

Feb 12, 2025

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Feb 12, 2025

Feb 08, 2025

SG Americas Securities LLC Has $209,000 Stock Holdings in Levi Strauss & Co. (NYSE:LEVI) - American Banking and Market News

Feb 08, 2025

Feb 08, 2025

SG Americas Securities LLC Has $206,000 Stake in Kodiak Sciences Inc. (NASDAQ:KOD) - Defense World

Feb 08, 2025

Feb 06, 2025

Diabetic Retinopathy Market on Track for Major Expansion by 2034, According to DelveInsight | Novartis, Kodiak Sciences Inc., Regenxbio, Perfuse Therapeutics, Hoffmann-La Roche, Boehringer Ingelheim - Barchart

Feb 06, 2025

Feb 06, 2025

Diabetic Retinopathy Market on Track for Major Expansion - openPR

Feb 06, 2025

Feb 04, 2025

Quarterly Dosing Breakthrough: Kodiak's New Glaucoma Treatment Targets Root Causes - StockTitan

Feb 04, 2025

Feb 04, 2025

Kodiak Sciences Inc.'s (NASDAQ:KOD) institutional investors lost 23% over the past week but have profited from longer-term gains - Simply Wall St

Feb 04, 2025